PLoS ONE · 2019 · 199 citations · 17 references
MedicinePharmacologyPharmacotherapyCritical Care PharmacologyRenal Replacement TherapySepsisBiomarkers In SepsisContinuous Renal Replacement TherapySepsis ManagementSepsis PathophysiologySepsis PharmacotherapySeptic ShockAcute Inflammatory ResponseAcute Organ FailureEndotoxin QuantificationOrgan Failure ManagementRenal Support During Extracorporeal Membrane OxygenationSepsis-associated Cytokine ResponseSeptic Shock ManagementTumor Necrosis Factor Therapy
BACKGROUND: Endotoxin induces an inflammatory response, with secondary release of cytokines, which can progress to shock and multiple organ failure. We explored whether continuous renal replacement therapy (CRRT) using a modified membrane (oXiris) capable of adsorption could reduce endotoxin and cytokine levels in septic patients. METHODS: Sixteen patients requiring CRRT for septic shock-associated acute renal failure and who had endotoxin levels >0.03 EU/ml were prospectively randomized in a crossover double-blind design to receive CRRT with an oXiris filter or with a standard filter. Endotoxin and cytokine levels were measured at baseline and 1, 3, 8, 16 and 24 hours after the start of CRRT. Norepinephrine infusion rate and blood lactate levels were monitored. RESULTS: During the first filter treatment period, endotoxin levels decreased in 7 of 9 (77.8%) oXiris filter patients, but in only 1 of 6 (16.7%) standard filter patients (P = 0.02). Levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-8 and interferon (IFN)γ decreased more with the oXiris filter than with the standard filter. Lactate concentration decreased with oXiris (-1.3[-2.2 to -1.1] mmol/l, P = 0.02), but not with the standard filter (+0.15[-0.95 to 0.6]). The norepinephrine infusion rate was reduced during oXiris CRRT, but not during standard filter CRRT. In the second filter treatment period, there was no significant reduction in endotoxin or cytokine levels in either group. CONCLUSIONS: CRRT with the oXiris filter seemed to allow effective removal of endotoxin and TNF-α, IL-6, IL-8 and IFNγ in patients with septic shock-associated acute renal failure. This may be associated with beneficial hemodynamic effects.
17
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock
Dinna N. Cruz, Massimo Antonelli, Roberto Fumagalli et al. · JAMA · 2009 · 833 citations
Endotoxemia in Human Septic Shock
Robert L. Danner, Ronald J. Elin, J M Hosseini et al. · CHEST Journal · 1991 · 666 citations